Partnering : Making a difference with our partners
Tiprelestat – the tissue protective agent
tiakis Biotech AG welcomes joint research projects and alliances to explore new avenues for our development programs in the fields of pulmonary arterial hypertension, COVID-19 and the prevention of postoperative inflammatory complications following major surgery.
The Company is open to engage in strategic partnerships supporting us to advance our product Tiprelestat as fast as we can into the market. In this context, we are open to partnering in the fields of internationalization of our clinical programs, market preparation & regulatory approval and marketing & sales of our innovative product.
We are open for licensing and/or co-development agreements with pharmaceutical partners globally or for territorial licenses.
Get in Contact
phone: +49 431 8888 462